TrialJDR clinical and translational research2024

Periodontal Effects of the Reversible Dipeptidyl Peptidase 1 Inhibitor Brensocatib in Bronchiectasis.

J C Gunsolley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.